Tumor necrosis factor/cachectin as an effector of T cell-dependent immunopathology.
Grau
G E
GE
Department of Pathology, WHO-IRTC, University of Geneva, Switzerland.
Lambert
P H
PH
Vassalli
P
P
Piguet
P F
PF
D000818:Animals; D016207:Cytokines / Q000502:physiology; D003602:Cytotoxicity, Immunologic / Q000187:drug effects; D006801:Humans; D007249:Inflammation / Q000139:chemically induced / Q000276:immunology / Q000503:physiopathology*; D008221:Lymphoid Tissue / Q000502:physiology; D051379:Mice; D009928:Organ Specificity; D011994:Recombinant Proteins / Q000494:pharmacology / Q000633:toxicity; D013602:T-Lymphocytes, Cytotoxic / Q000276:immunology*; D014409:Tumor Necrosis Factor-alpha / Q000096:biosynthesis / Q000494:pharmacology / Q000502:physiology* / Q000633:toxicity
D016207:Cytokines; D011994:Recombinant Proteins; D014409:Tumor Necrosis Factor-alpha